API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. OCS.NASDAQ

Oculis Holding AG Ordinary shares (OCS NASDAQ) stock market data APIs

$11.95 0(0%) as of September 6, 2024
Price chart is built with Anychart

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company is based in Zug, Switzerland.

Oculis Holding AG Ordinary shares Financial Data Overview

11.95
11.95
-
11.975
11.94
9.05-14.465
499 M
41 745 K
871 K
-0.6
0.085
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'OCS',
Type: 'Common Stock',
Name: 'Oculis Holding AG Ordinary shares',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01BJ1BHZ3',
ISIN: NULL,
CUSIP: NULL,
CIK: '1953530',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-03-02',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Oculis Holding AG Ordinary shares Fundamental Data is available in our Financial Data APIs

  • Net Revenue 871 K
  • EBITDA -62 840 000
  • Earnings Per Share -1.66
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Oculis Holding AG Ordinary shares Earnings via APIs

  • Latest Release 2024-08-27
  • EPS/Forecast -0.48

Get Oculis Holding AG Ordinary shares End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Oculis Holding AG Ordinary shares latest news via APIs

Oculis Reports Q3 2023 Financial Results and Provides Company Update

Reported lead product candidate OCS-01 eye drop met both primary endpoints in Phase 3 OPTIMIZE trial for inflammation and pain after cataract surgery following positive readout of Stage 1 of the Phase...
  • EARNINGS RELEASES AND OPERATING RESULTS
  • HEALTH
  • NASDAQ:OCS
  • OCULIS OPERATIONS SARL
  • PRODUCT / SERVICES ANNOUNCEMENT

Oculis to Present at Upcoming November Investor Conferences

ZUG, Switzerland, and BOSTON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye c...
  • CALENDAR OF EVENTS
  • CONFERENCE CALLS/ WEBCASTS
  • NASDAQ:OCS
  • OCULIS HOLDING AG
Do you have any questions?
support@eodhistoricaldata.com